Tg(Nphs1-IL2RA)18Mska
Transgene Detail
|
Symbol: |
Tg(Nphs1-IL2RA)18Mska |
Name: |
transgene insertion 18, Taiji Matsusaka |
MGI ID: |
MGI:3762500 |
Synonyms: |
NEP25, Nphs1-CD25 |
Transgene: |
Tg(Nphs1-IL2RA)18Mska Location: unknown
|
Alliance: |
Tg(Nphs1-IL2RA)18Mska page
|
|
|
Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(Nphs1-IL2RA)18Mska expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
IL2RA (3559) |
|
|
|
|
|
Mutation details: A 5527 bp fragment of the mouse Nphs1 gene was used as the transgene promoter. Two ATG sequences in the first intron of the fragment were disrupted by site-directed mutagenesis to prevent initiation of transcription of Nphs1. A fragment containing the human IL2RA (CD25) cDNA, FLAG sequence, and polyadenylation signal of the human growth hormone gene were placed downstream of the Nphs1 fragment in a transgenic construct. The vector was injected into (C57BL/6 x DBA/2) x C57BL/6N fertilized eggs. Two lines 9 and 18 showed essentially the same phenotype, and line 18 was maintained by backcrossing with C57BL/6N mice. Immunohistochemistry demonstrated that the transgene is expressed in podocytes, and RT-PCR showed transgene expression in the brain and pancreas but not in other organs (heart, spleen, thymus, lung, or muscle).
(J:127013)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:127013 Matsusaka T, et al., Genetic engineering of glomerular sclerosis in the mouse via control of onset and severity of podocyte-specific injury. J Am Soc Nephrol. 2005 Apr;16(4):1013-23 |
All: |
16 reference(s) |
|